Skip to main content
Premium Trial:

Request an Annual Quote

CombiMatrix Takes $1.25M Milestone in Toppan Microarray Development Deal

NEW YORK, Dec. 2 (GenomeWeb News) - Acacia Research said today that its CombiMatrix microarray subsidiary has received a $1.25 million milestone payment from Toppan as part of a development agreement the companies entered in May.

The companies are co-developing a microarray product suite based on CombiMatrix's electrochemical detection technology. Upon commercialization, Toppan will manufacture microarrays for CombiMatrix or its partners and will share revenues and royalties from sales of the products.

CombiMatrix received an initial $1 million upfront payment from Toppan when the alliance was formed in May.

The Scan

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.

Study Offers Insights Into Role of Structural Variants in Cancer

A new study in Nature using cell lines shows that structural variants can enable oncogene activation.

Computer Model Uses Genetics, Health Data to Predict Mental Disorders

A new model in JAMA Psychiatry finds combining genetic and health record data can predict a mental disorder diagnosis before one is made clinically.

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.